Orchid gets EU nods for marketing Piperacillin Tazobactam injection

New Delhi, Aug 4 (UNI) Pharma major Orchid Chemicals and Pharmaceuticals today said it has received approvals for marketing Piperacillin and Tazobactam injections in the European Union countries.

''The company has got the approvals of its Marketing Authorisation (MA) for Piperacillin and Tazobactam for injection for marketing in the EU countries,'' it said in a statement.

''This is a very important milestone in our regulated generics plan. Through this approval, we are expanding into a new product range of premium Penicillin injectables and also foraying into the EU generics market,'' comany Managing Director K Raghavendra Rao said.

UNI AK SG ND1606